EBITDA was up 8.9% to ₹2,298.2 crore in the third quarter of this fiscal over ₹2,111 crore in Q3 FY24. Shares of Dr Reddy’s Laboratories Ltd ended at ₹1,289.35, down by ₹6.95, or 0.54%, on the BSE.
Dr Reddy’s Laboratories Q3 Results | Net profit up 3%, revenue grows 16%; numbers lower than expected
Share it
